Rheumatology 2001; 40: 640-644
© 2001 British Society for Rheumatology
Original Papers |
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis
Centre for Rheumatic Diseases, Glasgow Royal Infirmary, 84 Castle Street, Glasgow G4 0SF,
1 University Department of Medicine, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER and
2 Department of Applied Statistics, University of Reading, Reading, UK
Objective. To compare prevalent cardiovascular disease, conventional cardiovascular risk factors and thrombotic variables in a cohort with well-controlled rheumatoid arthritis (RA) and in population controls.
Methods. Seventy-six RA patients and 641 controls, randomly sampled from the local population in the North Glasgow MONICA study. Conventional cardiovascular risk factors (blood pressure, smoking, cholesterol) and thrombotic variables [fibrinogen, von Willebrand factor (vWF), tissue plasminogen activator antigen (t-PA), fibrin D-dimer, plasminogen activator inhibitor (PAI-1), plasma viscosity] were measured by standard procedures.
Results. RA patients had a significantly higher prevalence of angina pectoris (P=0.03). Stroke also tended to be more common in the RA group, but the difference did not reach statistical significance (P=0.08). Diastolic blood pressure was significantly higher and serum cholesterol significantly lower in the RA group than in controls. Current smoking habits and exercise history were similar in the two groups, although RA patients were more likely to have previously smoked. Significant elevations in several thrombotic predictors of cardiovascular disease (fibrinogen, vWF, t-PA antigen and fibrin D-dimer) were found in the RA group.
Conclusions. In this RA patient population, diastolic blood pressure was higher than in controls and thrombotic variables were elevated compared with controls. These features are identified as potential additional cardiovascular risk factors in the RA patients studied. Prospective studies of risk modification may permit the identification of factors which could lead to a reduction in the known increased cardiovascular risk in RA.
KEY WORDS: Rheumatoid arthritis, Cardiovascular disease, Risk factors, Thrombotic variables.
Correspondence to: A. McEntegart.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Meune, E. Touze, L. Trinquart, and Y. Allanore Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies Rheumatology, October 1, 2009; 48(10): 1309 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. F. Panoulas, G. S. Metsios, A. V. Pace, H. John, G. J. Treharne, M. J. Banks, and G. D. Kitas Hypertension in rheumatoid arthritis Rheumatology, September 1, 2008; 47(9): 1286 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ugurlu, E. Seyahi, and H. Yazici Prevalence of angina, myocardial infarction and intermittent claudication assessed by Rose Questionnaire among patients with Behcet's syndrome Rheumatology, April 1, 2008; 47(4): 472 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Metsios, A. Stavropoulos-Kalinoglou, J. J. C. S. Veldhuijzen van Zanten, G. J. Treharne, V. F. Panoulas, K. M. J. Douglas, Y. Koutedakis, and G. D. Kitas Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review Rheumatology, March 1, 2008; 47(3): 239 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. F. Panoulas, H. J. Milionis, K. M. J. Douglas, P. Nightingale, M. D. Kita, R. Klocke, M. S. Elisaf, and G. D. Kitas Association of serum uric acid with cardiovascular disease in rheumatoid arthritis Rheumatology, September 1, 2007; 46(9): 1466 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. F. Panoulas, K. M. J. Douglas, H. J. Milionis, A. Stavropoulos-Kalinglou, P. Nightingale, M. D. Kita, A. L. Tselios, G. S. Metsios, M. S. Elisaf, and G. D. Kitas Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis Rheumatology, September 1, 2007; 46(9): 1477 - 1482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Montagna, F. Cacciapuoti, R. Buono, D. Manzella, G. A. Mennillo, A. Arciello, G. Valentini, and G. Paolisso Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis Diabetes and Vascular Disease Research, June 1, 2007; 4(2): 130 - 135. [Abstract] [PDF]
|
|
|
|
 |
|
 K M J Douglas, A V Pace, G J Treharne, A Saratzis, P Nightingale, N Erb, M J Banks, and G D Kitas Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome Ann Rheum Dis, March 1, 2006; 65(3): 348 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. Hall and N. Dalbeth Disease modification and cardiovascular risk reduction: two sides of the same coin? Rheumatology, December 1, 2005; 44(12): 1473 - 1482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Turiel, R Peretti, P Sarzi-Puttini, F Atzeni, and A Doria Cardiac imaging techniques in systemic autoimmune diseases Lupus, September 1, 2005; 14(9): 727 - 731. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Wei, T. M. MacDonald, and B. R. Walker Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease Ann Intern Med, November 16, 2004; 141(10): 764 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yildirim, S. Karatay, M. A. Melikoglu, G. Gureser, M. Ugur, and K. Senel Associations between Acute Phase Reactant Levels and Disease Activity Score (DAS28) in Patients with Rheumatoid Arthritis Ann. Clin. Lab. Sci., October 1, 2004; 34(4): 423 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Krishnan, V. B. Lingala, and G. Singh Declines in Mortality From Acute Myocardial Infarction in Successive Incidence and Birth Cohorts of Patients With Rheumatoid Arthritis Circulation, September 28, 2004; 110(13): 1774 - 1779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Kitas and N. Erb Reply Rheumatology, January 1, 2004; 43(1): 114 - 114. [Full Text] [PDF]
|
|
|
|
|
|
N. Sattar, D. W. McCarey, H. Capell, and I. B. McInnes Explaining How "High-Grade" Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis Circulation, December 16, 2003; 108(24): 2957 - 2963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Turesson, W M O'Fallon, C S Crowson, S E Gabriel, and E L Matteson Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years Ann Rheum Dis, August 1, 2003; 62(8): 722 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Kitas and N. Erb Tackling ischaemic heart disease in rheumatoid arthritis Rheumatology, May 1, 2003; 42(5): 607 - 613. [Full Text] [PDF]
|
|
|
|
 |
|
 P Brawarsky, D R Brooks, N Wilber, R E Gertz Jr, and D Klein Walker Tobacco use among adults with disabilities in Massachusetts Tob. Control, June 1, 2002; 11(90002): ii29 - 33. [Abstract] [Full Text]
|
|
|
|
|
|
A T MASI, J C ALDAG, R L MALAMET, D HUTCHINSON, and R MOOTS Heavy cigarette smoking and RA Ann Rheum Dis, December 1, 2001; 60(12): 1154 - 1155. [Full Text] [PDF]
|
|